Table 1

Demographic and clinical data for children with and without escalation of asthma therapy*

Total study population (n=14 029)Escalation of therapy (n=1020)No escalation of therapy (n=13 009)P value
Age in years, median (IQR)3 (1–5)3 (1–6)3 (1–5)0.09†
Male gender, n (%)8825 (62.9)635 (62.3)8190 (63.0)0.61‡
Australasian Triage Category 1–2, n (%)§4401 (31.4)690 (67.6)3711 (28.6)<0.001‡
Australasian Triage Category§
 Category 1, n (%)91 (0.6)48 (4.7)43 (0.3)
 Category 2, n (%)4310 (30.7)642 (62.9)3668 (28.2)
 Category 3, n (%)7950 (56.7)317 (31.1)7633 (58.7)
 Category 4, n (%)1633 (11.6)13 (1.3)1620 (12.5)
 Category 5, n (%)37 (0.3)0 (0)37 (0.3)
Hospital length of stay in hours, median (IQR)7.4 (3.7–19.6)44.2 (27.3–64.2)6.7 (3.5–16.3)<0.001†
ED disposition, n (%)
 Home5028 (35.8)5 (0.5)5023 (38.6)<0.001‡
 ED observation/short stay unit5234 (37.3)80 (7.8)5154 (39.6)
 Admission to ward3471 (24.7)725 (71.1)2746 (21.1)
 Admission to ICU in same hospital160 (1.1)156 (15.3)4 (0.03)
 Interhospital transfer78 (0.6)54 (5.3)24 (0.2)
 Left before treatment completed51 (0.4)0 (0)51 (0.4)
 Missing data7 (0.05)0 (0)7 (0.05)
  • *Defined as any of intensive care admission, invasive or non-invasive respiratory support, or parenteral bronchodilator therapy.

  • †Mann-Whitney U test.

  • ‡ χ2 test.

  • §Data missing for triage category for eight patients.

  • ED, emergency department; ICU, intensive care unit.